The goal of this project is to identify the genetic factors that predispose to canine narcolepsy. The first specific aim is to clone canarc-1, an autosomal recessive gene that produces canine narcolepsy. A very tight linkage marker for canarc-1 has been identified. This marker, a 0.85 kb band cross-hybridizing with a human p-switch Heavy- Chain immunoglobulin (Ig) probe (LOD score=13.6 at 0% recombination), has now been cloned and sequenced. Similar to the organization of Ig switch genes, it is composed of GC-rich 79-82 bp repeats and is 75% homologous to the human p-switch gene. We will use chromosome walking and Yeast Artificial Chromosome cloning techniques, together with corresponding studies in humans to identify the pathological gene. Narcoleptic dogs will then be used to study the gene functionally using in situ hybridization techniques and transgenic-related technologies. The second specific aim is to study the involvement of Dog Leucocyte Antigen (DLA) related genes in the canine pathology. Using Mixed Leucocyte Culture (MLC) techniques, we could not find any haplotype sharing in unrelated narcoleptic dogs. Recent experiments have shown that linkage disequilibrium between specific DR and DQ alleles is not very tight in dogs. Consequently, all our narcoleptic animals could share a common HLA DQ allele that would not have been detected using MLC. Alternatively all alleles carried could share a significant portion of their sequence. We will, therefore, clone and sequence the DQA1 and DQB1 alleles of a few narcoleptic dogs to test this hypothesis. This study should be facilitated by the fact that canine DQ sequences are now readily available. The third specific aim is to study Class Il expression in the brain of narcoleptic dogs. HLA antigens have been shown to be overexpressed in the brain of a number of immune pathologies, and we think this study could be very informative.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
3P50NS023724-12S1
Application #
6296928
Study Section
Project Start
1998-06-01
Project End
1999-05-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Bonvalet, Melodie; Ollila, Hanna M; Ambati, Aditya et al. (2017) Autoimmunity in narcolepsy. Curr Opin Pulm Med 23:522-529
Plante, David T; Finn, Laurel A; Hagen, Erika W et al. (2016) Subjective and Objective Measures of Hypersomnolence Demonstrate Divergent Associations with Depression among Participants in the Wisconsin Sleep Cohort Study. J Clin Sleep Med 12:571-8
Ollila, Hanna M; Ravel, Jean-Marie; Han, Fang et al. (2015) HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am J Hum Genet 96:136-46
Li, Jason; Moore 4th, Hyatt; Lin, Ling et al. (2015) Association of low ferritin with PLM in the Wisconsin Sleep Cohort. Sleep Med 16:1413-1418
Kornum, Birgitte Rahbek; Pizza, Fabio; Knudsen, Stine et al. (2015) Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset. Brain Behav Immun 49:54-8
Kawai, Makoto; O'Hara, Ruth; Einen, Mali et al. (2015) Narcolepsy in African Americans. Sleep 38:1673-81
Holm, Anja; Lin, Ling; Faraco, Juliette et al. (2015) EIF3G is associated with narcolepsy across ethnicities. Eur J Hum Genet 23:1573-80
Jacob, Louis; Leib, Ryan; Ollila, Hanna M et al. (2015) Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain Behav Immun 47:44-57
de Lecea, Luis (2015) Optogenetic control of hypocretin (orexin) neurons and arousal circuits. Curr Top Behav Neurosci 25:367-78
Wendt, Sabrina L; Welinder, Peter; Sorensen, Helge B D et al. (2015) Inter-expert and intra-expert reliability in sleep spindle scoring. Clin Neurophysiol 126:1548-56

Showing the most recent 10 out of 55 publications